Relay Therapeutics® is a clinical-stage precision medicine company that sits at the intersection of computational and experimental technologies. We are focused on making small molecule medicines against precision medicine targets with our objective being to make the discovery of medicines both more efficient and effective. Relay Therapeutics was built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights are driven by our Dynamo platform, which integrates an array of leading-edge experimental and computational approaches and enables us to effectively drug protein targets that have previously been intractable or inadequately addressed.